Back to Journals » Neuropsychiatric Disease and Treatment » Investigating the Role of Ketamine and Its Enantiomers in Bipolar Depression
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4185)
- Volume 20, 2024 (79)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Journal Articles:
- Epileptic disorders: advances in the diagnostic and therapeutic strategies (2)
- The effectiveness of non-pharmacological interventions for people with cognitive dysfunction (1)
- Stroke and neurorestoratology (1)
- Suicide Prevention and Intervention: Recent Evidence and Future Directions (4)
- Family and Peer Facilitated/Led Interventions for Severe Mental Health Problems (2)
- Autism, the disorder without borders and geopolitical variations (3)
- Therapeutic Response to Psychedelic Therapy – Who, What, Why & How? (3)
- Beneath the surface: genetic factors in schizophrenia (2)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
- Issues and Solutions in Autism Spectrum Disorders (ASD) (9)
- Cariprazine in schizophrenia (5)
- The Caregiver Perspective on Pediatric ADHD (3)
- Volume 7 - Supplement 1 (5)
- Volume 6 - Supplement 1 (6)
Investigating the Role of Ketamine and Its Enantiomers in Bipolar Depression
Bipolar depression (BD), affecting 2-3% of the global population, is a major research priority given the alarming suicide rates (5-10%) and a 30% non-response rate to existing treatments. The urgent need for innovative therapeutic strategies has led to interest in Ketamine and its enantiomers, including esketamine and arketamine, as potential options for BD treatment. However, robust evidence for ketamine's effectiveness in BD remains elusive, underscoring the necessity for thorough randomized studies, particularly those examining maintenance phase and long-term outcomes.